Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection

2018 ◽  
Vol 20 (9) ◽  
pp. 2113-2120 ◽  
Author(s):  
Xiao-Xue Zhu ◽  
Da-Long Zhu ◽  
Xiao-Ying Li ◽  
Ya-Lin Li ◽  
Xiao-Wei Jin ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Patient Selection ◽  
Cell Function ◽  
Day Treatment ◽  
Pancreatic Β Cell ◽  
Β Cell ◽  
Glucokinase Activator ◽  
Β Cell Function

Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes

2002 ◽  
Vol 57 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Shin-ichi Gorogawa ◽  
Yoshitaka Kajimoto ◽  
Yutaka Umayahara ◽  
Hideaki Kaneto ◽  
Hirotaka Watada ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Type 2 Diabetes ◽  
Cell Function ◽  
Pancreatic Β Cell ◽  
Β Cell ◽  
Β Cell Function
Sign in / Sign up

Export Citation Format

Share Document